Catheter-based renal sympathetic denervation for the treatment of resistant hypertension: First experience in Greece with significant ambulatory blood pressure reduction

Hellenic Journal of Cardiology

Volumn 53, Issue 3, 2012, Pages 237-241

  Tsioufis, Costas ^a   Dimitriadis, Kyriakos ^a   Tsiachris, Dimitris ^a   Thomopoulos, Costas ^a   Kasiakogias, Alexandros ^a   Kordalis, Athanasios ^a   Kefala, Anna ^a   Kallikazaros, Ioannis ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Radiofrequency ablation; Renal sympathetic denervation; Resistant hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEPARIN; HYDROCHLOROTHIAZIDE; MORPHINE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CASE REPORT; CATHETER; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG DOSE REDUCTION; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; GREECE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY DENERVATION; KIDNEY FUNCTION; KIDNEY NERVE; LOCAL ANESTHESIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PERIOPERATIVE COMPLICATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RADIOFREQUENCY ABLATION; RESISTANT HYPERTENSION; SYMPATHETIC NERVE;

AGED; BLOOD PRESSURE MONITORING, AMBULATORY; CATHETER ABLATION; GREECE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; SYMPATHECTOMY;

EID: 84865631009     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tsioufis C, Kordalis A, Flessas D, et al. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens. 2011; 2011: 642416.
2. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997; 77: 75-197.
3. Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation and systemic hypertension. Am J Cardiol. 2010; 105: 570-576.
4. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009; 361: 932-934.
5. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009; 373: 1275-1281.
6. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010; 376: 1903-1909.
7. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25: 1105-1187.
8. Page IH, Heuer GJ. A surgical treatment of essential hypertension. J Clin Invest. 1935; 14: 22-26.
9. Papademetriou V, Doumas M, Tsioufis C. Renal sympathetic denervation for the treatment of difficult-to-control or resistant hypertension. Int J Hypertens. 2011; 2011: 196518.
10. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension. 2009; 54: 1195-1201.
11. Krum H, Barman N, Schlaich M, et al; Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011; 57: 911-917.
12. Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011; 123: 1940-1946.
13. Prochnau D, Lauten A, Busch M, Kuehnert H, Figulla HR., Surber R. Catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system for drug resistant hypertension in a patient with end-stage renal disease. Int J Cardiol. 2012; 154: e29-30.
14. Thompson KA, Kar S, Makkar R, Victor RG. Drug-resistant hypertension: is renal sympathetic denervation the answer? Curr Cardiol Rep. 2011; 13: 93-95.
15. Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011; 58: 559-565.
16. Ukena C, Mahfoud F, Kindermann I, et al. Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol. 2011; 58: 1176-1182.
17. Stefanadis C. Renal denervation in resistant hypertension: radiofrequency ablation and chemical denervation. Hellenic J Cardiol. 2011; 52: 481-482.